Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Medingenii Capital is a venture capital firm founded in Houston, Texas, with a mission to advance healthcare through the cultivation of innovative companies. The firm is composed of a diverse team of physicians and entrepreneurs who are dedicated to addressing significant challenges within the healthcare sector. Medingenii Capital focuses on early-stage investments, particularly in sectors such as Health Information Technology, Genomic Testing, Patient Engagement, and Medical Devices.
Currently, Medingenii Capital has made 65 investments and maintains a portfolio that includes 100 mentor companies. The firm actively participates in five angel networks and five international accelerators, showcasing its commitment to fostering healthcare innovation both locally and globally. Their strong connections within the Texas Medical Center ecosystem provide a unique advantage in scaling companies and driving substantial exits.
Medingenii Capital targets early-stage companies that deliver disruptive solutions to healthcare challenges. Their investment strategy encompasses several key sectors, including Health Information Technology, Genomic Testing, Patient Engagement, and Medical Devices. The firm seeks to invest in companies that demonstrate potential for significant impact within the healthcare landscape.
Check sizes are not publicly disclosed, but the firm is known to engage in pre-seed, seed, seed+, and Series A funding rounds. Medingenii Capital leverages its domain expertise and extensive connections within the Texas Medical Center ecosystem to help portfolio companies scale effectively. They look for founders who possess a strong vision and the ability to navigate the complexities of the healthcare industry.
Medingenii Capital has a diverse portfolio that includes 100 mentor companies and 65 investments. Notable investments include:
While the firm has made numerous investments, the full list of portfolio companies is not publicly disclosed. However, their focus on healthcare innovation positions them well within the medical and life sciences sectors.
Gen Fukunaga — General Partner. Gen has a background in healthcare investment and entrepreneurship, contributing to the firm's strategic direction.
Greg Campbell — Managing Partner. Greg is the President & CEO of Rainmaker, Inc., and co-founder of the North Texas Opportunity Fund, with extensive experience in angel investing.
Diane Yoo — Managing Partner. Diane is a CEO of a woman and minority-owned business, focusing on scaling companies across various sectors, including consumer goods and technology.
Eddie Patton — General Partner. Eddie is recognized for his role as a founder and general partner, bringing valuable insights into the investment process.
Sreedhar Mandayam — General Partner. Sreedhar is a healthcare entrepreneur with expertise in chronic kidney disease care and nephrology clinical trials, contributing to the firm's healthcare focus.
To pitch Medingenii Capital, founders should use the contact form available on their website at medingenii.com. It is important to include a comprehensive pitch deck that outlines the problem, solution, market opportunity, and team background. Founders should expect a response time of several weeks, as the firm reviews pitches thoroughly.
Warm introductions are preferred, especially from individuals within the healthcare sector or those connected to the Texas Medical Center ecosystem.
As of April 2021, Medingenii Capital's last verified investment activity was in September 2020 with VISIE. Since then, public sources have not confirmed any new investments or significant announcements. Founders should verify the current status of the firm and its investment activity before proceeding.
Despite the lack of recent public deal activity, Medingenii Capital remains engaged in the healthcare startup ecosystem through its participation in five angel networks and five international accelerators.
What are Medingenii Capital's investment criteria?
Medingenii Capital invests in early-stage companies that provide disruptive solutions to healthcare challenges, particularly in Health Information Technology, Genomic Testing, Patient Engagement, and Medical Devices.
How can I pitch to Medingenii Capital?
Founders can pitch Medingenii Capital through their website at medingenii.com. It is advisable to include a clear description of the problem being solved, the solution offered, and the market opportunity.
What makes Medingenii Capital different from other investors?
Medingenii Capital's unique advantage lies in its deep connections within the Texas Medical Center ecosystem, which provides portfolio companies with access to healthcare operators and physician advisors.
What is the geographic focus of Medingenii Capital?
The firm primarily focuses on investments in North America, specifically the United States, leveraging its Houston base and connections.
What is the typical check size for investments?
While specific check sizes are not disclosed, Medingenii Capital engages in pre-seed, seed, seed+, and Series A funding rounds, indicating a focus on early-stage investments.
What kind of support do portfolio companies receive?
Medingenii Capital provides strategic guidance, mentorship, and access to a network of healthcare professionals to help portfolio companies scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.